Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLOG
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
.png)
Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
On Demand Webinar: Fill/Finish Services - Outsourced Pharma Capacity Update
Seeking an experienced fill/finish partner with available capacity today? You have come to the right place.
.png)
On-Demand Webinar: Outsourced Pharma Capacity Update - Fill/Finish
Are you an innovative company seeking a reliable CDMO partner for your drug product projects? Look no further.
Revised Annex 1 and the Focus on Microbial Control Strategies
The updates to EU Annex 1 added a great deal of emphasis on microbial control. By performing gap assessments and developing thorough, site-specific...
Building Velocity into Fill/Finish Timelines: Your Guide to Quality and Regulatory Success in the CDMO Space
Manufacturing capabilities need innovation proportional to those in therapeutics discovery. Choosing a CDMO partner with the technologies and...
Successful Development and Manufacturing of Vaccines Containing Aluminum Adjuvants
When added to vaccines, adjuvants such as aluminum salts can provide various benefits to drug products. Understanding the challenges associated with...
